MITS IMMUNKULUS, OOO, Moscow

Accounting reports

Previously

Contacts

Name	MEDITSINSKIY ISSLEDOVATEL'SKIY TSENTR IMMUNKULUS, OOO
INN	7735109078
KPP	771901001
OGRN	1027700306875
OKPO	58201855
Address	105187, G.MOSKVA, proezd. Okruzhnoy, d. 30A
Phone	780-72-87 Contact details

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities MITS IMMUNKULUS, OOO according to EGRUL
86.21	Core activity	General practice
21.20.2	Additional activity	Production of materials used in medical applications
71.20.9	Additional activity	Activities for technical control, testing and other analysis
All types of activities
72.19	Additional activity	Research and experimental development on natural sciences and engineering Other
86.10	Additional activity	Hospitals
86.90.9	Additional activity	Other independent activities in health care

Registration information

Registration date	11.10.2002
Registering department	Gosudarstvennoe uchrezhdenie Moskovskaya registratsionnaya palata

Description

MITS IMMUNKULUS, OOO (Moscow; INN 7735109078) was registered on 11 Oct 2002. The company's authorized capital as of July 1, 2012 was 20000 rub.

Type of ownership of MITS IMMUNKULUS, OOO - Limited liability companies.

Form of ownership of MITS IMMUNKULUS, OOO - Private property.

Principal activities of MITS IMMUNKULUS, OOO: general practice (86.21), production of materials used in medical applications (21.20.2), activities for technical control, testing and other analysis (71.20.9).

Industry

21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
- 21.2 - The production of medicines and materials used in medical purposes
  - 21.20 - Manufacturers of drugs and pharmaceuticals and medical products
    - 21.20.2 - Production of materials used in medical applications
71 - Architectural and engineering activities and related technical consultancy
- 71.2 - Technical testing, analysis and certification
  - 71.20 - Technical testing, analysis and certification
    - 71.20.9 - Activities for technical control, testing and other analysis
72 - Scientific research and development
- 72.1 - Research and experimental development on natural sciences and engineering
  - 72.19 - Research and experimental development on natural sciences and engineering Other
86 - Health service
- 86.1 - Activity of hospital organizations
  - 86.10 - Hospitals
- 86.9 - Health service
  - 86.90 - Activities in the field of medicine other
    - 86.90.9 - Other independent activities in health care
- 86.2 - Medical and dental practice activities
  - 86.21 - General practice

Economic indicators

2023

Net profit (RAS) of MITS IMMUNKULUS, OOO dropped in 2023 2,159.67 times to 27.00 thousand RUB from 58.31 million RUB over the same period in 2022, the company informed.

Revenue increased in the accounting period by 30.23% to 29.00 million RUB from 22.27 million RUB over 2022.

2022

Net profit (RAS) of MITS IMMUNKULUS, OOO grew over 2022 49.00 times to 58.31 million RUB from 1.19 million RUB over 2021, the company informed.

Revenue increased in the accounting period by 29.01% to 22.27 million RUB from 17.26 million RUB over 2021.

2021

Net profit (RAS) of MITS IMMUNKULUS, OOO made up 1.19 million RUB over 2021 compared to net loss of 6.72 million RUB over 2020, the company informed.

Revenue increased in the accounting period 1.58 times to 17.26 million RUB from 10.96 million RUB over 2020.

2020

Net loss (RA) of MITS IMMUNKULUS, OOO made up 6.72 million RUB over 2020 compared to net profit of 7.76 million RUB over 2019, the company informed.

Revenue decreased in the accounting period by 24.23% to 10.96 million RUB from 14.47 million RUB in 2019.

2019

Net profit (RAS) of MITS IMMUNKULUS, OOO made up 7.76 million RUB over 2019 compared to net loss of 4.16 million RUB over 2018, the company informed.

Revenue increased in the accounting period by 30.00% to 14.47 million RUB from 11.13 million RUB over 2018.

2018

Net profit (RAS) of MITS IMMUNKULUS, OOO made up 3.57 million RUB over 2018 compared to net loss of 595.00 thousand RUB over 2017, the company informed.

Revenue increased in the accounting period by 30.20% to 11.13 million RUB from 8.55 million RUB over 2017; cost of goods sold decreased by 16.62% to 6.99 million RUB from 8.38 million RUB; sales profit went up 24.80 times to 4.14 million RUB from 167.00 thousand RUB.

2017

Net loss (RAS) of MITS IMMUNKULUS, OOO increased 16.53 times to 595.00 thousand RUB from 36.00 thousand RUB over 2016, the company informed.

Revenue increased in the accounting period 1.64 times to 8.55 million RUB from 5.21 million RUB over 2016; cost of goods sold grew 1.59 times to 8.38 million RUB from 5.28 million RUB; sales profit made up 167.00 thousand RUB compared to sales loss of 74.00 thousand RUB.

2016

Net loss (RAS) of MITS IMMUNKULUS, OOO dropped over 2016 4.86 times to 36.00 thousand RUB from 175.00 thousand RUB KAgent.Entities.Balance, the company informed.

Revenue decreased in the accounting period by 19.27% to 5.21 million RUB from 6.45 million RUB in 2015; cost of goods sold decreased by 12.90% to 5.28 million RUB from 6.06 million RUB; sales loss made up 74.00 thousand RUB compared to sales profit of 387.00 thousand RUB.

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 337 637

Reports

17 430 596

Rrocessed requests

Extract from EGRUL:

Today, 1:58 PM

Accounting reports:

Today, 2:01 PM